探索沉浸式虚拟现实康复对帕金森病的有效性:叙述性审查
Roxana Nartea1,2, Daniela Poenaru1,2, Mariana Isabela Constantinovici1,2
1Department of Physical and Rehabilitation Medicine, Carol Davila University of Medicine and Pharmacy, 050451 Bucharest, Romania.
Journal of clinical medicine
|October 16, 2025
概括
沉浸式基于虚拟现实的康复 (IVRBR) 显示出改善帕金森病 (PD) 患者的运动和认知功能的前景. 需要进一步的研究来确定其长期有效性和临床实施策略.
科学领域:
- 神经科学是一个神经科学.
- 康复医学 康复医学 康复医学
- 数字健康数字健康
背景情况:
- 帕金森病 (PD) 涉及运动和非运动障碍,影响患者的独立性和生活质量.
- 对于PD的康复计划必须是全面的,引人入胜的,并且可以适应个人需求.
- 沉浸式基于虚拟现实的康复 (IVRBR) 为应对这些挑战提供了一种新的方法.
研究的目的:
- 在过去十年中,审查有关IVRBR在帕金森病患者中的有效性,局限性和实施的文献.
- 综合有关IVRBR对运动,认知和情绪领域影响的证据.
- 确定未来的研究方向,以优化PD护理中的IVRBR.
主要方法:
- 在过去10年内发表在PubMed,Scopus和Web of Science上的研究的叙事综述.
- 包括来自随机对照试验 (RTC) 和非RTC的证据.
- 分析IVRBR的有效性,局限性和实施因素.
主要成果:
- IVRBR在改善PD患者的平衡,运动学习和双重任务性能方面显示出潜力.
- 有证据表明,IVRBR.BR的认知和情绪状态有所改善.
- 客观评估工具和机器学习可以增强个性化康复计划.
结论:
- IVRBR是帕金森病康复的可行和有吸引力的选择,补充了传统方法.
- 限制包括小样本大小,结果异质性和当前研究中的短后续持续时间.
- 未来的大规模RTC,标准化协议,成本效益分析和预测建模对于更广泛的临床采用至关重要.
更多相关视频
07:35Author Spotlight: Rehabilitation of Stroke Patients With a Digital Occupational Training System
Published on: December 29, 2023
1.9K
06:00A Rehabilitation Program of Exoskeleton-assisted Body Weight-Supported Treadmill Training with Non-immersive Virtual Reality for Stroke Patients
Published on: May 16, 2025
985
相关概念视频
Parkinson's Disease: Treatment
972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
